RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients.

Influence of CYP2C9 gene polymorphisms on response to glibenclamide in type 2 diabetes mellitus patients.

Add to Collection
2011 Aug Others A Surendiran, SC Pradhan, A Agrawal… - European journal of …, 2011 - Springer

Full Author : ['Surendiran, A', 'Pradhan, S C', 'Agrawal, Aparna', 'Subrahmanyam, D K S', 'Rajan, S', 'Anichavezhi, D', 'Adithan, C']
Journal Title : European journal of clinical pharmacology
Chapter : Section3
Journal Year : 2011
Cited by : 59.0

PURPOSE: The antidiabetic drug glibenclamide is metabolized by the enzyme cytochrome P450 2C9 (CYP2C9) encoded by the polymorphic gene CYP2C9. Previous studies involving healthy volunteers have shown a significant influence of variant CYP2C9 genotypes on ..... Read More

Keywords : ["type diabetes mellitus patient", "gene polymorphism", "response", "influence", "glibenclamide"]
PubMed Link : https://link.springer.com/article/10.1007/s00228-011-1013-8
Google Scholar Link : https://scholar.google.com/scholar?cites=784726779386999135&as_sdt=2005&sciodt=0,5&hl=en&num=20